StemCell Therapy

Preventive effects of SGLT2 inhibitors on incident hypertension in patients with diabetes who do not have hypertension ...  Nature.com

Read more:
Preventive effects of SGLT2 inhibitors on incident hypertension in patients with diabetes who do not have hypertension ... - Nature.com

Lexington-Fayette County health department organizing weekend diabetes awareness expo  WEKU

Excerpt from:
Lexington-Fayette County health department organizing weekend diabetes awareness expo - WEKU

Curbing the Price of Novel Diabetes and Obesity Medications  Yale School of Medicine

See more here:
Curbing the Price of Novel Diabetes and Obesity Medications - Yale School of Medicine

Stanford Health closing Livermore Diabetes and Bariatric Center  Pleasanton Weekly

Read more:
Stanford Health closing Livermore Diabetes and Bariatric Center - Pleasanton Weekly

The association of ALT to HDL-C ratio with type 2 diabetes in 5074 years old adults: a population-based study ...  Nature.com

Excerpt from:
The association of ALT to HDL-C ratio with type 2 diabetes in 5074 years old adults: a population-based study ... - Nature.com

VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO ...  PR Newswire

Read the rest here:
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO ... - PR Newswire

Understanding the Complexity of Hyperglycemic Emergencies: Exploring the Influence of the Type and Duration of ...  Cureus

Visit link:
Understanding the Complexity of Hyperglycemic Emergencies: Exploring the Influence of the Type and Duration of ... - Cureus

Healthy Living & Diabetes Awareness Fair 2024  University of New Mexico

Excerpt from:
Healthy Living & Diabetes Awareness Fair 2024 - University of New Mexico

What Every Parent Should Know About Raising a T1D Kid  Health Central

More:
What Every Parent Should Know About Raising a T1D Kid - Health Central

New findings on pancreatic anatomy may affect diabetes research and treatment  Medical Xpress

See the article here:
New findings on pancreatic anatomy may affect diabetes research and treatment - Medical Xpress

The role of yogurt in diabetes and obesity prevention  News-Medical.Net

View original post here:
The role of yogurt in diabetes and obesity prevention - News-Medical.Net

How exercising outdoors can prevent depression and diabetes  inews

Read more here:
How exercising outdoors can prevent depression and diabetes - inews

Heart of the Valley: Valley woman discusses how she improved her health following diabetes diagnosis  KRGV

Read this article:
Heart of the Valley: Valley woman discusses how she improved her health following diabetes diagnosis - KRGV

The Right Amount of Sleep Could Help Prevent This Extremely Common Disease  Inverse

See the original post:
The Right Amount of Sleep Could Help Prevent This Extremely Common Disease - Inverse

'Bread and Butter': Societies Issue T2D Management Guidance  Medscape

Continued here:
'Bread and Butter': Societies Issue T2D Management Guidance - Medscape

Glycemic index of diets: importance beyond diabetes control  The Hindu

Read more from the original source:
Glycemic index of diets: importance beyond diabetes control - The Hindu

She was fired after not endorsing Splenda-filled salads to people with diabetes. Why?  The Guardian

Originally posted here:
She was fired after not endorsing Splenda-filled salads to people with diabetes. Why? - The Guardian

MIAMI, April 15, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it has been accepted for a Featured Research Oral Presentation to present the Company’s CLEAR MIND Phase 2a study results. CLEAR-MIND is a Phase 2a randomized clinical trial evaluating Lomecel-BTM in mild Alzheimer’s Disease. In addition to the clinical study results, the Company has been accepted for a poster presentation at the 2024 Alzheimer’s Association International Conference (AAIC), to be held July 28 – August 1, 2024 in Philadelphia, PA, USA and online.

Here is the original post:
Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research...

OCALA, Fla., April 15, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM”) today announced that Charles Lapp, MD, is joining the company to help lead its efforts to develop Ampligen (rintatolimod) as a potential treatment for Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID.

Follow this link:
AIM ImmunoTech Announces Charles Lapp, MD, as a Consulting Medical Officer for its ME/CFS and Long COVID Programs

Clinical trial expected to commence in mid-2024 to evaluate the safety and preliminary anti-tumor activity of TTX-MC138 Clinical trial expected to commence in mid-2024 to evaluate the safety and preliminary anti-tumor activity of TTX-MC138

See the original post here:
TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors